December 8, 2024
Blood Clot Retrieval Devices Market

Rising Demand for Effective Thrombectomy Procedures Propelling the Growth of Blood Clot Retrieval Devices Market

Blood clot retrieval devices are medical instruments used to remove blood clots from arteries and veins. Such devices facilitate clot removal through minimally invasive endovascular procedures, thereby restoring blood circulation. The growing preference for less invasive surgical interventions among patients and physicians is making thrombectomy the preferred option to treat blockages caused due to thrombosis. The devices also enable clot removal while preserving blood vessel integrity. Advancements in design features such as navigability, flexibility, and biocompatibility of retrieval components have made these mechanical thrombectomy devices highly effective for procedural success.

The global blood clot retrieval devices market is estimated to be valued at USD 1.62 Bn in 2024 and is expected to reach USD 4.40 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 15.3% from 2024 to 2031.

Key Takeaways

Key players operating in the Blood clot retrieval devices are Stryker Corporation, Medtronic plc, Johnson & Johnson, Boston Scientific Corporation, Penumbra, Inc., Terumo Corporation, Edwards Lifesciences Corporation, Argon Medical Devices, Inc., Cook Medical Inc., Control Medical Technology, Acandis GmbH, Phenox GmbH, B. Braun Melsungen AG, Teleflex Incorporated, MicroVention, Inc., Merit Medical Systems, W. L. Gore & Associates, Inc., and Inari Medical, Inc.

The key opportunities in the market include growing demand for advanced multi-level clot retrieval devices from hospitals and catheterization labs. Technological advancements focusing on navigability, flexibility, and safety aspects are further expanding the application scope of thrombectomy systems.

Globally, the Blood Clot Retrieval Devices Market Growth is witnessing strong in major markets across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Increasing investments by market players for capacity expansion and new product launches in high growth markets will drive the global expansion of the blood clot retrieval devices market during the forecast period.

Market drivers

The growing prevalence of thrombotic disorders such as deep vein thrombosis and pulmonary embolism due to changing lifestyle patterns is a major driver for this market. Rising geriatric population who are more susceptible to these conditions will further propel the demand. Growing awareness regarding minimally invasive endovascular interventions and availability of reimbursement are encouraging the adoption of clot retrieval devices among healthcare facilities. Furthermore, continuous technological advancements in design and materials used for thrombectomy systems are helping optimize clinical outcomes, thereby fueling their adoption.

PEST Analysis

Political: The Blood Clot Retrieval Devices Market Analysis is regulated by government bodies that ensure the quality and safety of these devices. Any new devices require regulatory approval before being introduced in the market.

Economic: The availability of favorable reimbursement policies for thrombectomy procedures aids the growth of this market. However, high procedure costs can limit the adoption of premium clot retrieval devices in developing nations.

Social: Rising incidence of strokes globally due to unhealthy lifestyle changes is a key driver for this market. Growing awareness about minimally invasive thrombectomy is also supporting market growth.

Technological: Advancements in thrombectomy devices such as low-profile retrievers and stent retrievers have enabled treatment of complex clots. The introduction of MRI-compatible retrievers allows treatment monitoring via MRI.

The largest market for blood clot retrieval devices in terms of value is North America due to rising demand for minimally invasive stroke treatments in the US and Canada. Europe is another major regional market supported by increasing thrombectomy procedures for ischemic strokes.

The Asia Pacific market is poised to grow at the fastest pace during the forecast period. This is attributed to factors such as rising healthcare expenditures, growing disease prevalence, increasing demand for advanced thrombectomy devices from developing nations like China and India.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it

About Author - Money Singh

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc.  LinkedIn Profile

About Author - Money Singh

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc.  LinkedIn Profile

View all posts by About Author - Money Singh →